233 related articles for article (PubMed ID: 29879685)
21. A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice.
Troeung L; Arnold-Reed D; Chan She Ping-Delfos W; Watts GF; Pang J; Lugonja M; Bulsara M; Mortley D; James M; Brett T
Heart; 2016 Jun; 102(11):855-61. PubMed ID: 26864669
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patients.
Hendy LE; Spees LP; Tak C; Carpenter DM; Thomas KC; Roberts MC
Atherosclerosis; 2024 Jun; 393():117541. PubMed ID: 38677159
[TBL] [Abstract][Full Text] [Related]
23. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.
Wald DS; Wald NJ
J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
[TBL] [Abstract][Full Text] [Related]
25. The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia.
Thayabaran D; Tsui APT; Ebmeier S; Cegla J; David A; Jones B
J Clin Lipidol; 2023; 17(2):244-254. PubMed ID: 36870882
[TBL] [Abstract][Full Text] [Related]
26. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
27. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
29. Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care.
Jones M; Akyea RK; Payne K; Humphries SE; Abdul-Hamid H; Weng S; Qureshi N
J Pers Med; 2022 Feb; 12(3):. PubMed ID: 35330330
[TBL] [Abstract][Full Text] [Related]
30. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
[TBL] [Abstract][Full Text] [Related]
31. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
Chen CX; Hay JW
Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
[TBL] [Abstract][Full Text] [Related]
33. Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care.
Qureshi N; Akyea RK; Dutton B; Leonardi-Bee J; Humphries SE; Weng S; Kai J
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635577
[TBL] [Abstract][Full Text] [Related]
34. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
[TBL] [Abstract][Full Text] [Related]
35. Detection of familial hypercholesterolemia in patients from a general practice database.
Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
[TBL] [Abstract][Full Text] [Related]
36. The genetics and screening of familial hypercholesterolaemia.
Henderson R; O'Kane M; McGilligan V; Watterson S
J Biomed Sci; 2016 Apr; 23():39. PubMed ID: 27084339
[TBL] [Abstract][Full Text] [Related]
37. Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis.
Marquina C; Lacaze P; Tiller J; Riaz M; Sturm AC; Nelson MR; Ference BA; Pang J; Watts GF; Nicholls SJ; Zoungas S; Liew D; McNeil J; Ademi Z
Eur Heart J; 2022 Sep; 43(34):3243-3254. PubMed ID: 34788414
[TBL] [Abstract][Full Text] [Related]
38. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
[TBL] [Abstract][Full Text] [Related]
39. Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia.
Pears R; Griffin M; Futema M; Humphries SE
Curr Opin Lipidol; 2015 Jun; 26(3):162-8. PubMed ID: 25887683
[TBL] [Abstract][Full Text] [Related]
40. Genetic analysis of familial hypercholesterolaemia in Western Australia.
Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM
Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
